Answers are grounded in this paper and cite their sources.
Single institution report evaluates transfusion planning and decision making for gene therapy in sickle cell disease, indicating unique needs for management.
The transfusion support of patients with SCD during GT has unique considerations due to RBC transfusion requirements for HPC mobilization cycles. This single institution report will help support transfusion planning and decision making about the feasibility of transfusion support for patients with extensive RBC alloimmunization.
No takes yet. Share an insight, caveat, or question.
Fasano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: